Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags EVLO FDA Biotech
From Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Tickers FUSN LNTH NVS PNT
Tags Penny Stocks Market News Small Cap
From Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Tickers ADMP AGTC ANAB APTO
Tags Offerings Market News Small Cap
From Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
Tickers BABA BYDDY CP FB
Tags GOOGL NVS Markets
From Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
Tickers NVS
Tags Biotech Ukraine/Russia War Russia/Ukraine War
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
Tickers AAPL AMC AZN BABA
Tags PCRX FR:IPN CORT
From MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Tickers NVS PFE VYGR
Tags VYGR NVS Recent Press Releases
From Motley Fool
2 Top Stocks to Buy in March and Hold Forever
Tickers NVS RHHBY VIVO
Tags NVS VIVO Recent Press Releases
From Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
Tickers NVS
Tags General Benzinga Biotech
From Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
Tickers BIIB NVS RHHBY
Tags News General Benzinga
From Benzinga
Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing
Tickers CING JNJ NVS
Tags Penny Stocks General Partner Content
From Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
Tickers CRSP LLY NVS VRTX
Tags XLV LLY Market News
From Motley Fool
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
Tickers HCM JNJ NVS
Tags HCM Market News Benzinga
From Benzinga
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
Tickers NVS
Tags Benzinga breast cancer Health Care
From Benzinga
7 Drug Stocks To Consider After the Viatris Plunge
Tickers ABBV BMY GSK JNJ
Tags MRK GSK Market News
From InvestorPlace
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Tickers ADMA ANIK AQST AXDX
Tags News Offerings Market News
From Benzinga
Voyager Therapeutics Shares Jump On Novartis Option Agreement For Gene Therapy Programs
Tickers NVS VYGR
Tags Movers Market News Briefs
From Benzinga
Pharmaceutical Companies Are Reportedly Refocusing On Mysterious Rise In Shingles Infections As COVID Declines
Tickers GSK NNVC NVS
Tags NVS NANOVIRICIDES INC GSK
From Benzinga
Viatris Just Snagged a Major FDA Approval
Tickers ABBV NVS REGN RHHBY
Tags REGN SNY NVS
From Motley Fool
Consumer Spending, E-Commerce, and the Business of Lodging
Tickers ABBV ABNB ABT AGN
Tags ABNB ABT JD
From Motley Fool
36 Stocks To Watch After Biden's First State of The Union Address
Tickers ABBV ABT AMGN AOUT
Tags WBA BMY NVS
From Benzinga
This Biotech Company Reports Making Ground-Breaking Strides In Combating Solid Tumors
Tickers BMY NVS ONCY PFE
Tags Oncolytics Biotech Market News
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
Tickers AGIO AZN BMY GMED
Tags IBB GSK Earnings
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags RHHBY Biotech Phase 3 Trial
From Benzinga
New FDA program could boost drug development for rare diseases
Tickers NVS PFE PJP
Tags PFE PJP NVS
From MarketWatch
3 High-Yield Dividend Stocks to Buy and Hold for Decades
Tickers BCE KHC NVS WMT
Tags BCE KHC WMT
From Motley Fool
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
Tickers ALNY NVS REGN
Tags Earnings Biotech ALNY
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Tickers AGLE ALNY ALVR ARMP
Tags ALNY RARE General
From Benzinga
Molecular Partners, Novartis Submit Emergency Use Authorization Request For Ensovibep For COVID-19
Tickers MOLN NVS
Tags General Benzinga FDA
From Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
Tickers ABBV AMGN BMY CANF
Tags NVS BMY AMGN
From Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.